Relationship between quantitative radiographic assessments of interstitial lung disease and physiological and clinical features of systemic sclerosis-Reference-Cited by-同舟云学术

Relationship between quantitative radiographic assessments of interstitial lung disease and physiological and clinical features of systemic sclerosis

Published:2014-12-01 Issue:2 Volume:75 Page:374-381
ISSN:0003-4967
Container-title:Annals of the Rheumatic Diseases
language:en
Short-container-title:Ann Rheum Dis

Author:

Tashkin Donald P,Volkmann Elizabeth R,Tseng Chi-Hong,Kim Hyun J,Goldin Jonathan,Clements Philip,Furst Daniel,Khanna Dinesh,Kleerup Eric,Roth Michael D,Elashoff Robert

Publisher

BMJ

Subject

General Biochemistry, Genetics and Molecular Biology,Immunology,Immunology and Allergy,Rheumatology

Reference31 articles.

1. Cyclophosphamide versus placebo in scleroderma lung disease;Tashkin;N Engl J Med,2006

2. Predicting Lung function and treatment outcomes in scleroderma-related interstitial lung disease;Roth;Arthritis Rheum,2011

3. Treatment of scleroderma interstitial lung disease with cyclophosphamide is associated with less progressive fibrosis on serial thoracic high-resolution CT scan than placebo;Goldin;Chest,2009

4. Quantitative computer-aided assessment of one-year changes in fibrosis and other interstitial lung disease abnormalities in HRCT in scleroderma lung disease treated with oral cyclophosphamide;Kim;Eur Radiology,2011

5. Clinical course of lung physiology in patients with scleroderma and interstitial lung disease: Analysis of the Scleroderma Lung Study placebo group;Khanna;Arthritis Rheum,2011

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Screening and Monitoring of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases;Arthritis & Rheumatology;2024-07-08

2. 2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Screening and Monitoring of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases;Arthritis Care & Research;2024-07-08

3. Low-Carbon Monoxide Diffusing Capacity, Patient-Reported Measures and Reduced Nailfold Capillary Density Are Associated with Interstitial Lung Disease in Systemic Sclerosis;Journal of Personalized Medicine;2024-06-14

4. Systemic sclerosis and interstitial lung disease: From pathogenesis, to screening, diagnosis, and classification;Revista Colombiana de Reumatología (English Edition);2024-04

5. The Performance of Pulmonary Function Tests in Predicting Systemic Sclerosis—Interstitial Lung Disease in the European Scleroderma Trial and Research Database;Diagnostics;2024-01-30